No CrossRef data available.
Article contents
Immune control in Kawasaki disease knowledge mapping: a bibliometric analysis
Published online by Cambridge University Press: 11 April 2024
Abstract
Background:
Kawasaki disease is a systemic vascular disease with an unclear pathophysiology that primarily affects children under the age of five. Research on immune control in Kawasaki disease has been gaining attention. This study aims to apply a bibliometric analysis to examine the present and future directions of immune control in Kawasaki disease.
Methods:
By utilizing the themes “Kawasaki disease,” “Kawasaki syndrome,” and “immune control,” the Web of Science Core Collection database was searched for publications on immune control in Kawasaki disease. This bibliometric analysis was carried out using VOSviewers, CiteSpace, and the R package “bibliometrix.”
Results:
In total, 294 studies on immune control in Kawasaki disease were published in Web of Science Core Collection. The three most significant institutions were Chang Gung University, the University of California San Diego, and Kaohsiung Chang Gung Memorial Hospital. China, the United States, and Japan were the three most important countries. In this research field, Clinical and Experimental Immunology was the top-referred journal, while the New England Journal of Medicine was the most co-cited journal. The Web of Science Core Collection document by McCrindle BW et al. published in 2017 was the most cited reference. Additionally, the author keywords concentrated on “COVID-19,” “SARS-CoV-2,” and “multisystem inflammatory syndrome in children” in recent years.
Conclusion:
The research trends and advancements in immune control in Kawasaki disease are thoroughly summarised in this bibliometric analysis, which is the first to do so. The data indicate recent research frontiers and hot directions, making it easier for researchers to study the immune control of Kawasaki disease.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
Footnotes
Lu Zhang, Lifeng Shi and Ruijie Zhang have equal contribution.
References
Kawasaki, T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16: 178–222.Google ScholarPubMed
Rife, E, Gedalia, A. Kawasaki disease: an update. Curr Rheumatol Rep 2020; 22: 75.CrossRefGoogle ScholarPubMed
Chen, D, Ireland, SJ, Remington, G, et al. CD40-mediated NF-kappaB activation in b cells is increased in multiple sclerosis and modulated by therapeutics. J Immunol 2016; 197: 4257–4265.CrossRefGoogle Scholar
Tomita, Y, Shimaya, M, Yamaura, Y, Tsujiguchi, R, Takahashi, K, Fukaya, T. Kawasaki disease: epidemiological differences between past and recent periods, and implications of distribution dynamism. Pediatr Int 2018; 60: 349–356.CrossRefGoogle ScholarPubMed
Mccrindle, BW, Rowley, AH, Newburger, JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation 2017; 135: e927–e999.CrossRefGoogle ScholarPubMed
Newburger, JW, Takahashi, M, Disease, JC. Kawasaki disease. J Am Coll Cardiol 2016; 67: 1738–1749.CrossRefGoogle ScholarPubMed
Tomar, N, De, RK. A brief outline of the immune system. Methods Mol Biol 2014; 1184: 3–12.CrossRefGoogle ScholarPubMed
Parkin, J, Cohen, B. An overview of the immune system. Lancet 2001; 357: 1777–1789.CrossRefGoogle ScholarPubMed
Takahashi, K, Oharaseki, T, Yokouchi, Y. Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 2014; 26: 31–36.CrossRefGoogle ScholarPubMed
Hara, T, Nakashima, Y, Sakai, Y, Nishio, H, Motomura, Y, Yamasaki, S. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol 2016; 186: 134–143.CrossRefGoogle ScholarPubMed
Shimizu, C, Oharaseki, T, Takahashi, K, Kottek, A, Franco, A, Burns, JC. The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol 2013; 44: 189–198.CrossRefGoogle ScholarPubMed
Rowley, AH, Shulman, ST, Mask, CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182: 1183–1191.CrossRefGoogle ScholarPubMed
Guo, MM, Tseng, WN, Ko, CH, Pan, HM, Hsieh, KS, Kuo, HC. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 2015; 70: 310–318.CrossRefGoogle ScholarPubMed
Wang, B, Xing, D, Zhu, Y, Dong, S, Zhao, B. The state of exosomes research: a global visualized analysis. Biomed Res Int 2019; 2019: 1495130.Google ScholarPubMed
Ke, L, Lu, C, Shen, R, Lu, T, Ma, B, Hua, Y. Knowledge mapping of drug-induced liver injury: a scientometric investigation 2010-2019. Front Pharmacol 2020; 11: 842.CrossRefGoogle ScholarPubMed
Ellegaard, O, Wallin, JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics 2015; 105: 1809–1831.CrossRefGoogle ScholarPubMed
Ninkov, A, Frank, JR, Maggio, LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ 2022; 11: 173–176.CrossRefGoogle ScholarPubMed
Wu, H, Cheng, K, Guo, Q, et al. Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: a bibliometric analysis. Front Med (Lausanne) 2021; 8: 787228.CrossRefGoogle ScholarPubMed
Shi, S, Gao, Y, Liu, M, et al. Top 100 most-cited articles on exosomes in the field of cancer: a bibliometric analysis and evidence mapping. Clin Exp Med 2021; 21: 181–194.CrossRefGoogle Scholar
Teles, R, Yano, RS, Villarinho, NJ, et al. Advances in breast cancer management and extracellular vesicle research, a bibliometric analysis. Curr Oncol 2021; 28: 4504–4520.CrossRefGoogle ScholarPubMed
Oo, S, Fan, KH, Khare, Y, et al. Top 100 cited manuscripts in aortic valve replacement: a bibliometric analysis. J Card Surg 2020; 35: 2943–2949.CrossRefGoogle ScholarPubMed
Tan, W, Jing, L, Wang, Y, Li, W. A global bibliometric analysis on Kawasaki disease research over the last 5 years (2017-2021. Front Public Health 2022; 10: 1075659.CrossRefGoogle ScholarPubMed
Wu, F, Gao, J, Kang, J, Wang, X, Niu, Q, Liu, J, Zhang, L. Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis 2002-2021. Front Immunol 2022; 13: 939433.CrossRefGoogle ScholarPubMed
Hirsch, JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci U S A 2005; 102: 16569–16572.CrossRefGoogle ScholarPubMed
Dey, M, Zhao, SS. COVID-19 and Kawasaki disease: an analysis using Google Trends. Clin Rheumatol 2020; 39: 2483–2484.CrossRefGoogle ScholarPubMed
Kabeerdoss, J, Pilania, RK, Karkhele, R, Kumar, TS, Danda, D, Singh, S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 2021; 41: 19–32.CrossRefGoogle Scholar
Virani, SS, Alonso, A, Benjamin, EJ, et al. Heart disease and stroke statistics-2020 update: a report from the american heart association. Circulation 2020; 141: e139–e596.CrossRefGoogle ScholarPubMed
Huang, YH, Lin, KM, Ho, SC, Yan, JH, Lo, MH, Kuo, HC. Increased incidence of kawasaki disease in taiwan in recent years: a 15 years nationwide population-based cohort study. Front Pediatr 2019; 7: 121.CrossRefGoogle Scholar
Singh, S, Vignesh, P, Burgner, D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child 2015; 100: 1084–1088.CrossRefGoogle ScholarPubMed
Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease; Clinical Research Center for Childhood Diseases of Shaanxi Province; Children’s Hospital of Shaanxi Provincial People’s Hospital, et al. Shaanxi provincial diagnosis and treatment center of kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi, 2021; 23: 867–876.Google Scholar
Bornmann, L, Pudovkin, AI. The journal impact factor should not be discarded. J Korean Med Sci 2017; 32: 180–182.CrossRefGoogle Scholar
Miao, Y, Zhang, Y, Yin, L. Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis. Peerj 2018; 6: e5477.CrossRefGoogle ScholarPubMed
Noval, RM, Arditi, M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol 2020; 16: 391–405.CrossRefGoogle Scholar
Zhu, F, Ang, JY. Update on the clinical management and diagnosis of Kawasaki disease. Curr Infect Dis Rep 2021; 23: 32021.CrossRefGoogle ScholarPubMed
Aldawas, A, Ishfaq, M. COVID-19: multisystem inflammatory syndrome in children (MIS-C). Cureus 2022; 14: 2022–e21064.Google ScholarPubMed
Lamrani, L, Manlhiot, C, Elias, MD, et al. Kawasaki disease shock syndrome vs classical Kawasaki disease: a meta-analysis and comparison with SARS-CoV-2 multisystem inflammatory syndrome. Can J Cardiol 2021; 37: 1619–1628.CrossRefGoogle ScholarPubMed
Okazaki, K, Matsui, K, Takahashi, N, Miura, M, Kondo, M. Kawasaki disease in a preterm neonate: case report and cytokine profile. Pediatr Int 2018; 60: 1037–1039.CrossRefGoogle Scholar
Rowley, AH, Baker, SC, Kim, KA, et al. Allograft inflammatory factor-1 links T-cell activation, interferon response, and macrophage activation in chronic kawasaki disease arteritis. J Pediatric Infect Dis Soc 2017; 6: e94–e102.CrossRefGoogle ScholarPubMed
Wang, Y, Qian, SY, Yuan, Y, et al. Do cytokines correlate with refractory Kawasaki disease in children? Clin Chim Acta 2020; 506: 222–227.CrossRefGoogle ScholarPubMed
Porritt, RA, Chase, HC, Dick, EJ, et al. Inhibition of IL-6 in the LCWE mouse model of kawasaki disease inhibits acute phase reactant serum amyloid a but fails to attenuate vasculitis. Front Immunol 2021; 12: 630196.CrossRefGoogle ScholarPubMed
Ferdosian, F, Dastgheib, SA, Morovati-Sharifabad, M, et al. Cumulative evidence for association between IL-10 polymorphisms and kawasaki disease susceptibility: a systematic review and meta-analysis. Fetal Pediatr Pathol 2021; 40: 153–165.CrossRefGoogle ScholarPubMed
Koizumi, K, Hoshiai, M, Moriguchi, T, et al. Plasma exchange downregulates activated monocytes and restores regulatory t cells in kawasaki disease. Ther Apher Dial 2019; 23: 92–98.CrossRefGoogle ScholarPubMed
Jindal, AK, Rawat, A, Goel, S, et al. Expression of CD40 ligand on t cells and soluble CD40 ligand in children with kawasaki disease: a single-center preliminary study from north india. J Clin Rheumatol 2021; 27: 194–200.CrossRefGoogle Scholar
Raj, N, Reidy-Lagunes, D. Current clinical trials of targeted agents for well-differentiated neuroendocrine tumors. Pancreas 2014; 43: 1185–1189.CrossRefGoogle ScholarPubMed
Jing, Y, Ding, M, Fu, J, Xiao, Y, Chen, X, Zhang, Q. Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC. Biosci Rep 2020; 40: BSR20200928.CrossRefGoogle ScholarPubMed
Ge, X, Li, CR, Yang, J, Wang, GB. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease. Scand J Immunol 2013; 77: 389–397.CrossRefGoogle ScholarPubMed
Lee, Y, Wakita, D, Dagvadorj, J, et al. IL-1 signaling is critically required in stromal cells in kawasaki disease vasculitis mouse model: role of both IL-1alpha and IL-1beta. Arterioscler Thromb Vasc Biol, 2015, 35:2605–2616.CrossRefGoogle Scholar
Lin, IC, Kuo, HC, Lin, YJ, et al. Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. Plos One 2012; 7: e38635.CrossRefGoogle Scholar